Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:COCH NASDAQ:OBIO NASDAQ:RXST NASDAQ:VANI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$0.76+5.1%$0.69$0.36▼$1.89$55.62M1.88843,698 shs1.04 million shsOBIOOrchestra BioMed$3.72+1.9%$4.00$2.20▼$5.42$218.57M0.49498,018 shs186,891 shsRXSTRxSight$5.57+6.1%$5.31$4.48▼$13.22$217.33M1.151.43 million shs2.37 million shsVANIVivani Medical$1.35-4.3%$1.24$0.92▼$1.92$121.59M2.331.02 million shs649,470 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical+5.06%+11.62%+17.23%+7.27%-53.08%OBIOOrchestra BioMed+1.92%-5.10%-3.38%-18.78%+18.10%RXSTRxSight+6.10%+9.65%+19.02%-26.81%-23.49%VANIVivani Medical-4.26%-13.46%+15.38%+0.75%-16.67%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$0.76+5.1%$0.69$0.36▼$1.89$55.62M1.88843,698 shs1.04 million shsOBIOOrchestra BioMed$3.72+1.9%$4.00$2.20▼$5.42$218.57M0.49498,018 shs186,891 shsRXSTRxSight$5.57+6.1%$5.31$4.48▼$13.22$217.33M1.151.43 million shs2.37 million shsVANIVivani Medical$1.35-4.3%$1.24$0.92▼$1.92$121.59M2.331.02 million shs649,470 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical+5.06%+11.62%+17.23%+7.27%-53.08%OBIOOrchestra BioMed+1.92%-5.10%-3.38%-18.78%+18.10%RXSTRxSight+6.10%+9.65%+19.02%-26.81%-23.49%VANIVivani Medical-4.26%-13.46%+15.38%+0.75%-16.67%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOCHEnvoy Medical 2.00Hold$2.50228.90% UpsideOBIOOrchestra BioMed 2.57Moderate Buy$13.60265.59% UpsideRXSTRxSight 1.92Reduce$8.8959.59% UpsideVANIVivani Medical 2.25Hold$3.75177.78% UpsideCurrent Analyst Ratings BreakdownLatest COCH, VANI, OBIO, and RXST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/15/2026COCHEnvoy Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.507/7/2026RXSTRxSight Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$6.507/7/2026VANIVivani Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)7/7/2026RXSTRxSight Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderperform$8.00 ➝ $6.507/7/2026RXSTRxSight Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$11.006/23/2026VANIVivani Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/23/2026VANIVivani Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$4.006/23/2026VANIVivani Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$4.006/11/2026RXSTRxSight Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/9/2026VANIVivani Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/22/2026RXSTRxSight Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)(Data available from 7/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOCHEnvoy Medical$240K243.49N/AN/A($0.42) per share-1.81OBIOOrchestra BioMed$33.48M6.65N/AN/A$0.95 per share3.92RXSTRxSight$134.48M1.71N/AN/A$6.70 per share0.83VANIVivani MedicalN/AN/AN/AN/A$0.20 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOCHEnvoy Medical-$23.76M-$1.01N/AN/AN/A-9,875.64%N/A-177.92%7/30/2026 (Estimated)OBIOOrchestra BioMed-$52.70M-$0.97N/AN/AN/A-166.96%-157.46%-60.18%8/11/2026 (Estimated)RXSTRxSight-$38.94M-$1.13N/AN/AN/A-36.58%-17.01%-15.12%8/5/2026 (Estimated)VANIVivani Medical-$26.61M-$0.40N/AN/AN/AN/A-264.04%-79.85%8/12/2026 (Estimated)Latest COCH, VANI, OBIO, and RXST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2026Q2 2026VANIVivani Medical-$0.08N/AN/AN/AN/AN/A8/11/2026Q2 2026OBIOOrchestra BioMed-$0.35N/AN/AN/A$0.14 millionN/A8/5/2026Q2 2026RXSTRxSight-$0.21N/AN/AN/A$32.47 millionN/A7/30/2026Q2 2026COCHEnvoy Medical-$0.08N/AN/AN/A$0.10 millionN/A5/13/2026Q1 2026VANIVivani Medical-$0.08-$0.08N/A-$0.08N/AN/A5/12/2026Q1 2026OBIOOrchestra BioMed-$0.40-$0.33+$0.07-$0.33$0.92 million$0.11 million5/11/2026Q1 2026COCHEnvoy Medical-$0.14-$0.11+$0.03-$0.08$0.10 million$0.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCOCHEnvoy MedicalN/AN/AN/AN/AN/AOBIOOrchestra BioMedN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/AVANIVivani MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOCHEnvoy MedicalN/A2.272.14OBIOOrchestra BioMed0.357.037.01RXSTRxSightN/A10.208.93VANIVivani MedicalN/A3.183.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOCHEnvoy Medical8.59%OBIOOrchestra BioMed53.20%RXSTRxSight78.78%VANIVivani Medical6.78%Insider OwnershipCompanyInsider OwnershipCOCHEnvoy Medical7.10%OBIOOrchestra BioMed7.50%RXSTRxSight10.05%VANIVivani Medical53.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOCHEnvoy Medical3476.88 million71.42 millionNot OptionableOBIOOrchestra BioMed459.88 million55.39 millionNot OptionableRXSTRxSight22041.40 million37.24 millionOptionableVANIVivani Medical2086.24 million40.27 millionOptionableCOCH, VANI, OBIO, and RXST HeadlinesRecent News About These CompaniesVivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk DealJuly 15 at 7:01 PM | marketbeat.comVivani Medical to Present at the Emerging Growth Conference on July 15, 2026July 14 at 4:03 PM | globenewswire.comNext Frontier In Weight Loss? New Implant Looks To Lock In GLP-1 ResultsJuly 14 at 8:19 AM | msn.comThe next GLP-1 bet? Implant draws Novo interestJuly 13, 2026 | beckershospitalreview.comBVivani MedicalJuly 13, 2026 | fool.comWeight-loss implant could one day replace Ozempic injectionsJuly 12, 2026 | msn.comAnalysts Set Expectations for Vivani Medical Q1 EarningsJuly 10, 2026 | marketbeat.comNovo Nordisk (CPSE:NOVO B) Could Be 13% Overvalued Following Its Vivani DealJuly 9, 2026 | finance.yahoo.comVivani Medical signs agreement with Novo Nordisk to evaluate NPM-139July 9, 2026 | pharmabiz.comPOzempic & Wegovy maker to evaluate long-acting GLP-1 implant that could last up to a yearJuly 9, 2026 | msn.comNovo Nordisk pens long-acting GLP-1 implant tech deal with Vivani MedicalJuly 7, 2026 | fiercebiotech.comFNovo Nordisk (CPSE:NOVO B) Teams Up With Vivani To Test A Semaglutide ImplantJuly 7, 2026 | finance.yahoo.comVivani Medical (NASDAQ:VANI) versus Biostar Pharmaceuticals (OTCMKTS:BSPM) Critical SurveyJuly 7, 2026 | americanbankingnews.comVivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight ManagementJuly 7, 2026 | globenewswire.comVivani strikes reverse-merger agreement with ClearOne for BCI businessJuly 3, 2026 | finance.yahoo.comClearOne to Merge With Vivani Medical Subsidiary CortigentJuly 2, 2026 | marketwatch.comVivani to sell neurotech subsidiary Cortigent to ClearOneJuly 2, 2026 | massdevice.comClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani MedicalJuly 2, 2026 | businesswire.comVivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.July 2, 2026 | globenewswire.comVivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement ...June 26, 2026 | caledonianrecord.comCVivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean BakerJune 26, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCOCH, VANI, OBIO, and RXST Company DescriptionsEnvoy Medical NASDAQ:COCH$0.76 +0.04 (+5.06%) Closing price 07/16/2026 04:00 PM EasternExtended Trading$0.78 +0.02 (+2.62%) As of 09:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Orchestra BioMed NASDAQ:OBIO$3.72 +0.07 (+1.92%) Closing price 07/16/2026 04:00 PM EasternExtended Trading$3.72 +0.00 (+0.13%) As of 07:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.RxSight NASDAQ:RXST$5.57 +0.32 (+6.10%) Closing price 07/16/2026 04:00 PM EasternExtended Trading$5.46 -0.11 (-1.97%) As of 09:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Vivani Medical NASDAQ:VANI$1.35 -0.06 (-4.26%) Closing price 07/16/2026 04:00 PM EasternExtended Trading$1.40 +0.05 (+3.70%) As of 09:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Has Broadcom Become Too Expensive for Its AI Story? The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet Palantir's Wild Ride: Inside the Stock Wall Street Can't Agree On Revving Up Returns: Big Banks Race Through the Rate Plateau Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase Japan’s Crypto Overhaul Could Open the Door to a Wave of Institutional Money Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
